TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 52 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,220 | -87.7% | 17,964 | -87.5% | 0.00% | -100.0% |
| Q2 2023 | $2,602,387 | +275.4% | 144,017 | +161.1% | 0.00% | – |
| Q1 2023 | $693,311 | -21.9% | 55,156 | -8.9% | 0.00% | – |
| Q4 2022 | $887,912 | +33.3% | 60,567 | +55.7% | 0.00% | – |
| Q3 2022 | $666,000 | -21.9% | 38,900 | -33.4% | 0.00% | – |
| Q2 2022 | $853,000 | +102.1% | 58,373 | +132.6% | 0.00% | – |
| Q1 2022 | $422,000 | – | 25,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |